BeiGene Revenue

In the year 2024, BeiGene had annual revenue of 3.81B CNY with 54.96% growth. BeiGene had revenue of 1.13B in the quarter ending December 31, 2024, with 75.39% growth.

Revenue

3.81B

Revenue Growth

+54.96%

P/S Ratio

n/a

Revenue / Employee

2.62M

Employees

10,600

Market Cap

211.24B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.81B	1.35B	54.96%
Dec 31, 2023	2.46B	1.04B	73.65%
Dec 31, 2022	1.42B	239.64M	20.37%
Dec 31, 2021	1.18B	867.41M	280.83%
Dec 31, 2020	308.87M	-119.34M	-27.87%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Shenzhen Mindray Bio-Medical Electronics	37.11B
Jiangsu Hengrui Medicine	26.00B
WuXi AppTec	38.50B
Aier Eye Hospital Group	20.62B
Zhangzhou Pientzehuang Pharmaceutical.,	10.91B
Shanghai United Imaging Healthcare	10.30B
Yunnan Baiyao Group Co.,Ltd	39.34B
Sichuan Biokin Pharmaceutical	5.85B

Revenue Rankings

BeiGene News

1 day ago - BeiGene, Ltd. (ONC) Q4 2024 Earnings Call Transcript - Seeking Alpha
2 days ago - BeiGene Ltd (ONC) Q4 2024 Earnings: EPS of -$0.11 Beats Estimates, Revenue Surges to $1.1 Billion - GuruFocus
2 days ago - BeiGene reports Q4 results - Seeking Alpha
8 days ago - Hang Seng Index left untouched, but tweaks made to tech, China enterprises indices - South China Morning Post
10 days ago - BeiGene (ONC) Stock Rises on Nomura's Optimistic Outlook - GuruFocus
4 weeks ago - ImmunityBio announces collaboration with Beigene - Seeking Alpha

More News